Cardima Revelation Tx Receives Second Rejection Letter, May Need New Data
This article was originally published in The Gray Sheet
Executive Summary
Cardima may have to collect additional data on its Revelation Tx cardiac ablation catheter to earn FDA approval for an atrial fibrillation indication, the company acknowledged June 2